A New Paradigm for the Management of Mild Asthma
Paul M. O’Byrne, MB, FRCP (C ), FRSC
Topics: Asthma
Details
Objectives
- The evolution of asthma management recommendations for mild asthma.
- The challenges with the use of maintenance inhaled corticosteroids (ICS) in mild asthma.
- The risks of relying on short-acting inhaled ß2 agonists as the only asthma treatment.
- The benefits of ICS/formoterol as a reliever in mild asthma.
Faculty
Paul M. O’Byrne MB, FRCP (C ), FRSC
Michael G. DeGroot School of Medicine
Distinguished University Professor, McMaster University
Paul M. O’Byrne obtained his Medical Degree at University College, Dublin. He is currently the Dean and Vice President of the Faculty of Health Sciences at McMaster University. His research interests focus on the mechanisms and treatment of asthma. He has published more than 500 peer reviewed papers, and has an h-index (Google Scholar) of 115. His accolades include the James H. Graham Award of Merit of the Royal College of Physicians and Surgeons of Canada; election to the Royal Society of Canada; the European Respiratory Society Congress Award and Medal; election to the Canadian Academy of Health Sciences; and, McMaster’s top academic award, Distinguished University Professor. In 2017, the American College of Chest Physicians named him a Giant of Chest Medicine and more recently, he received an Honorary Life Achievement Award from the Ontario Thoracic Society, the Jack Hirsh Award for Outstanding Academic Achievement from McMaster University and Medical Graduate Distinguished Alumnus Award from University College, Dublin.